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Interstitial microdeletions of 20q chromosome are rare, only 17
patients have been reported in the literature to date. Among them,
only six carried a proximal 20q11.21-q11.23 deletion, with a size
ranging from 2.6 to 6.8 Mb. The existence of a 20q11.2 micro-
deletion syndrome has been proposed, based on five previously
reported cases that displayed anomalies of the extremities, intel-
lectual disability, feeding difficulties, craniofacial dysmorphism
and variable malformations. To further characterize this syn-
drome, we report on six new patients with 20q11.2 microdeletions
diagnosed by whole-genome array-based comparative genomic
hybridization. These patient reports more precisely refined the
phenotype and narrowed the minimal critical region involved in
this syndrome. Careful clinical assessment confirms the distinc-
tive clinical phenotype. The craniofacial dysmorphism consists of
high forehead, frontal bossing, enophthalmos, and midface hypo-
plasia. We have identified a 1.62 megabase minimal critical region
involved in this syndrome encompassing three genes - GDF5,
EPB41L1, andSAMHD1– which are strong candidates for different
aspects of the phenotype. These results support that 20q11.2
microdeletion syndrome is a new contiguous gene deletion syn-
drome with a recognizable phenotype.  2014 Wiley Periodicals, Inc.
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INTRODUCTION
Interstitial microdeletions of the chromosome 20q region are rare.
To our knowledge, only 17 patients have been reported in the
literature to date [Fraisse et al., 1981 Petersen et al., 1987; Porfirio
et al., 1987; Shabtai et al., 1993; Aldred et al., 2002; Chen et al., 2005;
Genevie`ve et al., 2005; Callier et al., 2006; Borozdin et al., 2007; Iqbal
and Al-Owain, 2007; Hiraki et al., 2011; Gervasini et al., 2013;
Iourov et al., 2013; Santoro et al., 2013; Posmyk et al., 2014] and
only six of these patients carried a proximal 20q11.2 deletion, with a
size ranging from 2.6 to 6.8 Mb [Callier et al., 2006; Iqbal and Al-
Owain, 2007; Hiraki et al., 2011; Gervasini et al., 2013; Iourov et al.,
2013; Posmyk et al., 2014]. Intellectual disability, craniofacial
dysmorphism, anomalies of the extremities and feeding difficulties
are recurrent clinical features in these patients, suggesting a recog-
nizable microdeletion syndrome. We report on a study of six new
patients harbouring a de novo 20q11.21-q11.23 microdeletion;
these patients presented with a suggestive phenotype. Comparison
of the deleted regions in these patients allowed more precise
characterization of the critical region responsible for the phenotype,
and discussion of genotype/phenotype correlations.
CLINICAL REPORTS
The phenotypic features of the six new unrelated patients and the
five previously reported patients with 20q11.2 microdeletion are
summarized in Table I. Clinical data and informed consents were
obtained from all patients or their legal representatives.
Patient 1
Patient 1 was a 15-year-old boy, the second child of unrelated healthy
parents with no family history of malformation. He was born at 41
weeks of gestation (WG) after an uneventful pregnancy. At birth, he
weighed 3,030 g (45th centile) and presented with global hypotonia,
poor movements, a right supernumerary nipple, facial dysmor-
phism (Fig. 1 and Table I) and anomalies of the extremities (Figs.
2 and 3, and Table I). The subsequent course was marked by delayed
psychomotor acquisitions with moderate intellectual disability. At
age 15, he was unable to read or write despite management in a
specialized school, and he was unable to dress by himself. He had
mild features of autism spectrum disorder such as hand and finger
biting, avoidance of eye contact, and social difficulties. Changes in
facial dysmorphism were noted during the follow-up with the
disappearance of microretrognathia and short philtrum, and the
appearance of deep-set eyes and midface hypoplasia (Fig. 1). Growth
was within normal range with a height of 180 cm (90th centile),
weight of 75 kg (90th centile) and head circumference of 59 cm (90th
centile) at the age of 15. Hearing tests showed a 50 dB deficit on the
right side. Ophthalmological examination, visual evoked potentials,
electroencephalogram, brain MRI, electrocardiogram, abdominal
ultrasound and echocardiography were normal.
Patient 2
Patient 2 was a 5.5-year-old boy with no family history of malfor-
mation. He was born at 40 WG after a pregnancy without medical
supervision. Birth weight was 2,700 g (20th centile). He presented
with global hypertonia, anomalies of both hands and feet, and facial
dysmorphism (Table I). Anomalies of the extremities consisted of
fifth finger clinodactyly, left-sided single transverse palmar crease,
and talipes varus. The subsequent course was marked by severe
psychomotor and language delay: he began sitting over 1 year of age,
waking independently at the age of 3 years, and spoke his first words
over 5 years of age. When he was 5.5 years old, height was 107.6 cm
(9th centile), weight was 21.6 kg (50th–75th centile) and head
circumference was 53 cm (50th centile). Facial dysmorphism con-
sisted of facial asymmetry, frontal bossing, deep-set eyes, midface
hypoplasia, and short philtrum. Ophthalmological examination
showed intermittent strabismus. Hearing testing was normal. No
other malformations were detected.
Patient 3
Patient 3 was a 6-year-old boy with no family history of malforma-
tion. He was born at 39 WG after a pregnancy without medical
supervision with a birth weight of 3,385 g (75–90th centile). At birth,
he presented with global hypotonia, anomalies of the extremities
(Fig. 2 and Table I), mild pectus carinatum and facial dysmorphism
(Fig.1 and Table I). The subsequent course was marked by devel-
opmental delay: he was able to sit from the age of 1 year and able to
walk independently from the age of 2.5 years. Language was more
severely affected: the first single words appeared at the age of 2 years
3 months. He was able to read a few words from the age of 6 years
after management in a specialized school. At the age of 6 years,
height was 104 cm (0.4th–2nd centile), weight was 15.9 kg (0.4th–2nd
centile) and head circumference was 50.5 cm (2nd–9th centile). X-
rays of the extremities showed shortening of proximal and middle
phalanges of second fingers, shortening of the middle phalanges of
fifth fingers, and eleven pairs of ribs. He did not present any hearing
anomalies or other malformations.
Patient 4
Patient 4 was a 2.5-year-old boy born at 32 WG after a spontaneous
triplet trichorionic triamniotic pregnancy. At birth, weight was
1,210 g (2nd centile) and head circumference was 27.5 cm (2nd–9th
centile). He presented with global hypotonia, facial dysmorphism
(Fig. 1 and Table I) and anomalies of the extremities (Fig. 2 and
Table I). The first weeks of life were marked by feeding difficulties
and oesophageal reflux requiring gastrostomy. At the age of 8
months, facial dysmorphism consisted of sparse hair, broad and
high forehead, hypertelorism, mild downslanting palpebral fis-
sures, deep-set eyes, midface hypoplasia, short philtrum, micro-
retrognathia, and small ears. When he was 2.5 years old, height was
86.5 cm (9th–25th centile), weight was 11.7 kg (9th centile) and head
circumference was 48 cm (2nd centile). Facial dysmorphism had
changed with disappearance of microretrognathia and appearance
of hypoplastic alae nasi and long columella (Fig. 1). The subsequent
course was marked by severe psychomotor retardation: he was
unable to stand at 2.5 years of age and was delayed in oral language
(limited to three words at the age of two years). Growth was normal.
At birth, brain MRI showed delayed myelination and thickening of
the ventricles. He presented no hearing impairment or other
malformations.
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FIG. 1. Facial dysmorphism. Common facial features are broad and high forehead with frontal bossing, deep-set eyes, midface hypoplasia and
ears anomalies. Patient 6 also had a microretrognathia.
FIG. 2. Hand anomalies in Patients 1, 3, and 6. Hand anomalies. Common features are 2nd (3rd) and 5th fingers brachydactyly,
camptodactyly and clinodactyly. Patient 6 had right pre-axial polydactyly and long fingers.
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Patient 5
Patient 5 was a 20-year-old woman with no family history of
psychomotor delay or malformation. She was born at term after
an uneventful pregnancy. At birth, weight was 3,000 g (10th centile)
and length was 51 cm (50th centile). Multiple congenital anomalies
were diagnosed, including total anomalous pulmonary venous
return requiring surgical treatment in the first week of life, bilateral
congenital talus valgus, hip dysplasia, right sacroiliac pit and
covered anus and facial dysmorphism (Fig. 1 and Table I). The
subsequent course was marked by mild developmental delay. No
delay of motor acquisitions was observed. Language developed
from the age of 3–4 years, and reading and writing were acquired
only from the age of 8 years, after intensive management in a
specialized school. Precocious puberty and an excessive weight gain
were noted during adolescence due to food-seeking behavior. At the
age of 20, she was able to read and write, had a job and lead a
relatively independent life. Height was 157 cm (10th–25th centile),
and weight was 57 kg (25th–50th centile). Changes in facial dys-
morphism were noted: the midface hypoplasia became more
obvious with time. She also had tapered fingers and narrow calves.
Dermatological examination revealed multiple melanocytic naevi
and lentigines. Ophthalmological examination revealed unilateral
astigmatism and ptosis. Hearing tests showed bilateral high fre-
quency hearing loss. She had no other obvious malformations.
Patient 6
Patient 6 was a 2-month-old girl. Prenatal ultrasound found mild
intra-uterine growth restriction and oligohydramnios from 27 WG.
She was born at 39 WG with a birth weight of 2,268 g (0.4th–2nd
centile). She presented with global hypotonia, facial dysmorphism
(Fig. 1 and Table I) and digital anomalies (Fig. 2 and 3, and Table I).
During the first two months of life, she experienced feeding
difficulties with failure to thrive in a context of gastroesophageal
reflux and seizures. When she was two months old, weight was
2,900 g (0.4th–2nd centile) and head circumference was 35 cm
(0.4th–2nd centile). Her hand malformations consisted of right
pre-axial polydactyly and long fingers. She had long, overlapping
toes (Fig. 3). Brain MRI showed atrophy of the left hemisphere, and
unilateral end-stage periventricular leukomalacia. Echocardiogra-
phy revealed atrial septal defect, mitral incompetence and pulmo-
nary hypertension. She had no other obvious malformations.
METHODS
Chromosomal analyses were performed for all patients after obtain-
ing informed consent according to local legislation in each country.
Conventional karyotypes, FISH and quantitative PCR analyses were
performed according to standard methods on samples of peripheral
blood lymphocytes. Array CGHanalyses wereperformed usinga 44 K
array for Patients 1 and 3 (Agilent Technologies, Santa Clara, CA,
USA), 180K array for Patient 4 (Agilent Technologies, Santa Clara,
CA, USA), and a 60 K array (Bluegnome ISCA Cytochip, Cambridge,
UK) for Patients 2 and 5. A SNP array using an Affymetrix GeneChip
6.0 array (Affymetrix, Santa Clara, CA, USA) was performed for
Patient 6. Confirmation of these results and investigation of inheri-
tance were performed by analysing parental samples when available,
using quantitative PCR (Patients 1 and 4), FISH analyses (Patients 2,
3, and 5), or karyotype (Patient 6).
DNA sequence information for patients is presented according
to the UCSC Genome Browser (http://genome.ucsc.edu/; February
2009 Assembly, hg19).
RESULTS
Cytogenetics analyses were performed to explore a malformation
syndrome in each case. No anomalies were found on conventional
karyotypes. Array CGH analyses found a microdeletion of the
20q11.2 chromosomal region in all patients, with sizes ranging
FIG. 3. Feet anomalies in Patients 1 and 6. Patient 1 had bilateral talus valgus and hallux adductus. Patient 6 had long and overlapping toes.
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from 2.24 Mb to 7.7 Mb (Table II). Array-CGH also excluded the
involvement of another chromosomal imbalance in the phenotype.
Patients 1 to 4, who had a very similar phenotype, allow us to define
a minimal critical region measuring 1.62Mb (33,962,025–
35,580,928)(hg19) (Fig. 4). This region encompasses 29 genes
according to the UCSC Genome Browser. Three of these genes
are referenced in the OMIM database: GDF5, EPB41L1 and
SAMHD1. All breakpoints of the deleted regions were unique,
suggesting that these deletions were not generated by a non-allelic
homologous recombination mechanism. The deleted region in
Patient 5 did not include EPB41L1, and the deleted region in patient
6 did not include GDF5, as showed in Figure 4.
The de novo occurrence of the deletions was confirmed for
Patients 1, 2, 4, 5 and 6 by cytogenetic analysis of their parents.
An inherited form could not be excluded in Patient 3: the mother
did not carry the deletion and the father could not be tested.
DISCUSSION
We report on six new patients with a 20q11.2 microdeletion. They
shared common clinical features with previously reported patients.
Array CGH analyses refined the minimal critical deleted interval to
a 1.62 Mb region.
Only five patients with de novo interstitial 20q11.2 deletions have
been previously reported, and their cytogenetic results are summa-
rized in Figure 4 [Callier et al., 2006; Iqbal and Al-Owain, 2007;
Hiraki et al., 2011; Gervasini et al., 2013 ; Posmyk et al., 2014].
Another patient reported by Iourov et al. [2013] harboured a more
proximal deletion, with a different phenotype, and will be excluded
from the discussion.
Comparison of the clinical data of our 6 patients and those of the
five previously reported patients support the idea that the 20q11.2
microdeletion causes a recognizable clinical phenotype. Ten of the
11 patients presented with anomalies of the extremities. Both hands
and feet were affected with extremely variable degrees of severity.
The most common signs in these patients were finger clinodactyly
(6/11), camptodactyly (4/11), brachydactyly (3/11) and feet mal-
position (7/11). The anomalies observed in Patient 1 can be
classified as type A2 brachydactyly and those of Patient 3 can
be classified as type C brachydactyly. Two patients presented
with pre-axial polydactyly associated with other distal anomalies;
only Patient 6 presented with isolated pre-axial polydactyly.
Surprisingly, the patient reported by Gervasini et al. [2013] had
no anomaly of the extremities. Ten of the 11 patients presented with
feeding difficulties and failure to thrive during the first weeks of life.
Associated gastrointestinal anomalies were observed in 6 patients,
including gastroesophageal reflux, pyloric stenosis and oesophageal
hiatus hernia. Psychomotor delay was present in all 11 patients:
moderate to severe delay in both motor and language acquisitions
were noted in 10 patients. Only Patient 5 presented with mild
intellectual disability. A recognizable craniofacial dysmorphism
was suggested, which comprised of high forehead, enophthalmos,
abnormal ears, short philtrum and microretrognathia in
infants. Microretrognathia had resolved in the oldest patients
and, inversely, the chin became more prominent and midface
hypoplasia became more apparent. Furthermore, patients with
20q11.2 microdeletion exhibit occasional findings of variable
growth (7/11), behavioral disorders (5/10), hearing impairment
(4/9) and inconsistent malformations of the heart (6/11), eye (6/11)
and brain (5/10) were also noted (Table I).
At least three genes included in the common deleted region could
probably be responsible for a part of the associated phenotype.
Growth/Differentiation factor 5 (GDF5) – OMIM 601146–encodes
a secreted growth factor that plays a regulatory role in embryonic
skeletal and joint development in mice and chicks by modulation of
the BMP pathway [Storm and Kingsley, 1996; Merino et al., 1999].
Mutations of this gene induce various syndromes characterized by
skeletal malformations, depending on the site of the mutations and
their consequences for protein function [Temtamy and Aglan,
2008; Mundlos, 2009]. There is evidence that haploinsufficiency
of GDF5 is the mechanism responsible for type C brachydactyly, as
all the reported mutations are frameshift or missense heterozygous
mutations leading to loss of function of the protein [Everman et al.,
2002; Yang et al., 2008]. All patients, except for Patients 1 and 3,
presented with more variable associations of anomalies of the
extremities, suggesting another molecular pathogenesis in the
case of entire GDF5 deletions. Patient 6 harbored a deletion that
did not encompass GDF5, and she presented with a different
phenotype of the extremities with unilateral pre-axial polydactyly
and long fingers. The patients reported by Hiraki et al. [2011] and
Posmyk et al. [2014] also presented with pre-axial polydactyly,
suggesting the possible implication of another unknown genetic
factor located in this chromosomal region. Some heterozygous
GDF5 mutations are associated with hearing impairment, probably
due to abnormalities of middle ear bones. This possibly explains the
hearing impairment observed in four patients. GDF5 may also have
TABLE II. Summary of the Deleted Region (hg19)
Patient Microarray Deleted region Size Inheritance
1 Agilent 44K chr20:33,962,025-36,768,739 2.8 Mb de novo
2 ISCA Cytochip 60K chr20:32,945,492-37,263,920 4.3 Mb de novo
3 Agilent 44K chr20:33,834,793-37,945,599 4.1 Mb not determined
4 Agilent 180K chr20:33,097,682-35,580,928 2.48 Mb de novo
5 ISCA Cytochip 60K chr20:32,118,663-34,361,435 2.24 Mb de novo
6 AffymetrixGeneChip 6.0 chr20:34,194,054-41,958,122 7.7 Mb de novo
Array CGH results of patients with deletion 20q11.2.
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other pleiotropic effects: the influence of GDF5 on dendrite size and
morphology was demonstrated in a murine model, which could
explain part of the neurological phenotype observed in these
patients [Oso´rio et al., 2013].
Erythrocyte Membrane Protein Band 4.1-Like 1 (EPB41L1) –
OMIM 602879–is included in the critical deleted region and was
deleted in ten patients. EPB41L1 encodes a neuronal cytoskeletal
protein, called 4.1 N, that binds an AMPA receptor, GLUR1, and
regulates its expression at excitatory synapses [Shen et al., 2000]. A
missense loss-of-function mutation of EPB41L1 has been reported
in one case of nonsyndromic intellectual disability syndrome
(MRD11–OMIM 614257): the patient presented with hypotonia
and severe intellectual disability but with no cerebral malforma-
tions [Hamdan et al., 2011]. It can be hypothesized that haploin-
sufficiency of EPB41L1 results in decreased function of 4.1 N and is
responsible for part of the neurological phenotype of patients with a
20q11.2 deletion. Patient 5 harbored a deletion that did not
encompass EPB41L1, which could possibly explain her less severe
neurological phenotype.
SAMHD1–OMIM 606754–is the third gene of interest included
in the common deleted region. Bi-allelic mutations and/or dele-
tions in SAMHD1 have been associated with Aicardi-Goutieres
syndrome [Rice et al., 2009; Leshinsky-Silver et al., 2011]. Hetero-
zygous mutations in SAMHD1 are also known to be responsible for
a late-onset form of systemic lupus erythematosus and retinal
vasculopathy with cerebral leukodystrophy [Ravenscroft et al.,
2011]. Deletion of SAMHD1 could explain the cerebral malforma-
tions (cerebral atrophy in the three first patients reported, peri-
ventricular leukomalacia in Patient 6), and the retinal dysplasia
observed in the patients reported by Hiraki et al. [2011] and Posmyk
et al. [2014]. While systemic lupus erythematosus has not been
reported in the literature to date in any patients with 20q11.2
deletions, regular and long-term follow up would be important to
identify the potential onset of systemic lupus erythematosus in
these patients.
In conclusion, these findings confirm that deletion of chromo-
some 20q11.2 is responsible for a recognizable microdeletion
syndrome comprising anomalies of the extremities, distinctive
facial dysmorphism, intellectual disability, neonatal feeding diffi-
culties and hearing impairment. We hypothesize that three genes
are involved in the phenotype: GDF5 for anomalies of the extremi-
ties and hearing impairment, EPB41L1 for intellectual disability,
and SAMHD1 for cerebral malformation and retinal dysplasia. This
study supports that the 20q11.21q11.23 microdeletion syndrome
may be a newly recognized contiguous gene deletion syndrome.
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FIG. 4. Comparison of the deleted regions. Array CGH analyses refined the minimal critical region to a 1.62 Mb deletion, between 33,962,025
and 35,580,928 (hg19) (UCSC Genome Browser).
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